✦ LIBER ✦

751 The safety and efficacy of viramidine® plus pegylated interferon alpha-2B versus ribavirin plus pegylated interferon alpha-2B in therapy-naïve patients infected with HCV: Phase 3 results

✍ Scribed by Y. Benhamou; P. Pockros; M. Rodrieuez-Torres; S. Gordon; M. Shiffinan; Y. Lurie; N. Afdhal; K. Lamon; Y. Kim; B. Murphy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O.062 The safety and efficacy of Viramid

✍ B. Murphy 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Treatment of chronic hepatitis C in HIV

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

[10] THE SAFETY AND EFFICACY OF TARIBAVI

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Which is the real efficacy of pegylated

✍ Adriano M. Pellicelli; Mario Romano; Paolo Guarascio; Pascal Vignally 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Treatment of naïve hepatitis C recurrenc

✍ G.W. Neff; M. Montalbano; N. Ozden; H. Muslu; Y.M. Lee; G. Slapak; K. Safdar; R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Impact of early viral kinetics on pegyla

✍ H. Nomura; Y. Miyagi; H. Tanimoto; H. Ishibashi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB